Nordgren Johan, Sharma Sumit, Bucardo Filemon, Nasir Waqas, Günaydın Gökçe, Ouermi Djeneba, Nitiema Leon W, Becker-Dreps Sylvia, Simpore Jacques, Hammarström Lennart, Larson Göran, Svensson Lennart
Division of Molecular Virology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Sweden.
Department of Microbiology, University of León, Nicaragua.
Clin Infect Dis. 2014 Dec 1;59(11):1567-73. doi: 10.1093/cid/ciu633. Epub 2014 Aug 5.
The live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa. Recent in vitro studies have shown binding of the RV surface protein (VP4) to histo-blood group antigens (HBGAs) in an RV genotype-dependent manner, suggesting them to be putative receptors for RV. The diversity of HBGA phenotypes in different ethnic populations, combined with prevalence/absence of specific RV genotypes, led us to hypothesize whether the genetic variations in HBGAs in a population limit susceptibility to certain RV genotypes, plausibly leading to reduced vaccine efficacy.
Association between HBGAs status and susceptibility to RV P genotypes was investigated in children in Burkina Faso and Nicaragua. In total, 242 children with diarrhea in Burkina Faso and Nicaragua were investigated, 93 of whom were RV positive.
In Burkina Faso, the P[8] RV strains (n = 27) infected only Lewis- and secretor-positive children (27/27; P < .0001), but no Lewis-negative children. In contrast, the P[6] strains (n = 27) infected predominantly Lewis-negative children (n = 18; P < .0001) but also Lewis-positive children, irrespective of their secretor status. The results from Nicaragua confirmed that all P[8]-infected children (n = 22) were secretor Lewis positive.
As VP4 of genotype P[8] is a component of current RV vaccines, our finding that Lewis-negative children are resistant to P[8] strains provides a plausible explanation for the reduced vaccine efficacy in populations with a high percentage of Lewis-negative individuals, such as in Africa. Furthermore, our findings provide a plausible explanation as to why P[6] RV strains are more common in Africa.
口服轮状病毒(RV)活疫苗在非洲的效力有所降低。近期的体外研究表明,RV表面蛋白(VP4)以RV基因型依赖的方式与组织血型抗原(HBGA)结合,提示它们可能是RV的受体。不同种族人群中HBGA表型的多样性,加上特定RV基因型的流行情况,使我们推测人群中HBGA的基因变异是否会限制对某些RV基因型的易感性,这可能导致疫苗效力降低。
在布基纳法索和尼加拉瓜的儿童中研究了HBGA状态与对RV P基因型易感性之间的关联。总共对布基纳法索和尼加拉瓜的242名腹泻儿童进行了调查,其中93名RV呈阳性。
在布基纳法索,P[8] RV毒株(n = 27)仅感染Lewis阳性和分泌型阳性儿童(27/27;P <.0001),未感染Lewis阴性儿童。相比之下,P[6]毒株(n = 27)主要感染Lewis阴性儿童(n = 18;P <.0001),但也感染Lewis阳性儿童,无论其分泌型状态如何。尼加拉瓜的结果证实,所有感染P[8]的儿童(n = 22)均为Lewis阳性分泌型。
由于基因型P[8]的VP4是当前RV疫苗的一个成分,我们发现Lewis阴性儿童对P[8]毒株具有抗性,这为Lewis阴性个体比例较高的人群(如非洲人群)中疫苗效力降低提供了一个合理的解释。此外,我们的研究结果也为P[6] RV毒株在非洲更为常见提供了一个合理的解释。